Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization

Benefits of extended treatment with dalteparin in patients with unstable coronary artery disease eligible for revascularization.

AIMS The FRISC II trial demonstrated that, for patients with unstable coronary artery disease, an early invasive strategy following acute treatment with dalteparin and aspirin, was superior to a more conservative approach. We evaluated whether it is beneficial to extend treatment with dalteparin to patients eligible for revascularization but for whom these procedures are performed after the ini...

modern surgical techniques in treatment of patients with cleft lip & cleft palate

چکیده ندارد.

Evaluation of iron status in patients with coronary artery disease

Background: Iron can causes lipid peroxidation in vivo and in vitro. Iron  promotes myocardial injury in experimental animals. Low Density Lipoprotein (LDL) oxidation by oxidants including iron have a central role in atherosclerotic process. By this means, evaluation of serum iron in patients with coronary artery disease (CAD) has a significant importance. Materials and Methods: In this cross s...

evaluation of fat atrophy in patients with dermis fat graft of orbit by ct-scan

چکیده ندارد.

Association of Hyperhomocysteinemia with Coronary Artery Disease in Southern Iran